相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Potential of Afatinib inNRG1Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel et al.
ONCOLOGIST (2021)
MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions
Hiroki Sato et al.
CLINICAL CANCER RESEARCH (2020)
Characterization of NRG1 gene fusion events in solid tumors.
Sushma Jonna et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers
Morana Vojnic et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Detection of NRG1 Gene Fusions in Solid Tumors
Sushma Jonna et al.
CLINICAL CANCER RESEARCH (2019)
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
Lecia Sequist et al.
ONCOLOGIST (2019)
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
Cecile A. W. Geuijen et al.
CANCER CELL (2018)
Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers
Alexander Drilon et al.
CANCER DISCOVERY (2018)
Frequent NRG1 fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression
Domenico Trombetta et al.
Oncotarget (2018)
Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations
Gang G. Li et al.
CLINICAL CANCER RESEARCH (2017)
The Drug Repurposing Hub: a next-generation drug library and information resource
Steven M. Corsello et al.
NATURE MEDICINE (2017)
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)
Birgit Schoeberl et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung
Dong Hoon Shin et al.
ONCOTARGET (2016)
NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma
Michael Duruisseaux et al.
CANCER MEDICINE (2016)
BATF2 Deficiency Promote Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs
Zebing Liu et al.
CLINICAL CANCER RESEARCH (2015)
In vivo tumor growth of high-grade serous ovarian cancer cell lines
Anirban K. Mitra et al.
GYNECOLOGIC ONCOLOGY (2015)
Molecular Pathways: Targeting NRG1 Fusions in Lung Cancer
Lynnette Fernandez-Cuesta et al.
CLINICAL CANCER RESEARCH (2015)
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
David D. Bowtell et al.
NATURE REVIEWS CANCER (2015)
Molecular Pathways: HER3 Targeted Therapy
Kinisha Gala et al.
CLINICAL CANCER RESEARCH (2014)
CD74-NRG1 Fusions in Lung Adenocarcinoma
Lynnette Fernandez-Cuesta et al.
CANCER DISCOVERY (2014)
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
Qing Sheng et al.
CANCER CELL (2010)
An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation
Birgit Schoeberl et al.
CANCER RESEARCH (2010)
Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
Birgit Schoeberl et al.
SCIENCE SIGNALING (2009)
Identification and Preliminary characterization of novel Small Molecules that Inhibit Growth of Human Lung Adenocarcinoma cells
Romel Somwar et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells
M Sato et al.
CANCER RESEARCH (2006)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue™
H Gloeckner et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
分享论文
